Skip to content
10-Q

Quarterly Report

Foghorn Therapeutics Inc. FHTX

0001628280-25-037606

← back to feed
Filed
Aug 5, 2025 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q2 2025 · Jul 28, 2025 56.53M sh
Shares Diluted Q2 2025 · Jun 30, 2025 62.98M sh
Shares Diluted Q2 2025 · Jun 30, 2025 62.91M sh
Shares Diluted Q2 2025 · Jun 30, 2024 51.58M sh
Shares Diluted Q2 2025 · Jun 30, 2024 47M sh
Capex Q2 2025 · Jun 30, 2025 $50K
Capex Q2 2025 · Jun 30, 2024 $118K
Operating Cash Flow Q2 2025 · Jun 30, 2025 −$44.97M
Operating Cash Flow Q2 2025 · Jun 30, 2024 −$54.88M
Cash And Equivalents Q2 2025 · Jun 30, 2025 $72.57M
Cash And Equivalents Q2 2025 · Dec 31, 2024 $55.45M
Cash And Equivalents Q2 2025 · Jun 30, 2024 $138.95M
Stockholders Equity Q2 2025 · Jun 30, 2025 −$76.66M
Stockholders Equity Q2 2025 · Mar 31, 2025 −$61.65M
Stockholders Equity Q2 2025 · Dec 31, 2024 −$45.53M
Stockholders Equity Q2 2025 · Jun 30, 2024 −$14.32M
Stockholders Equity Q2 2025 · Mar 31, 2024 −$97.49M
Stockholders Equity Q2 2025 · Dec 31, 2023 −$77.19M
Current Liabilities Q2 2025 · Jun 30, 2025 $77.79M
Current Liabilities Q2 2025 · Dec 31, 2024 $66.99M
Total Liabilities Q2 2025 · Jun 30, 2025 $302.9M
Total Liabilities Q2 2025 · Dec 31, 2024 $329.51M
Current Assets Q2 2025 · Jun 30, 2025 $203.84M
Current Assets Q2 2025 · Dec 31, 2024 $249.6M
Total Assets Q2 2025 · Jun 30, 2025 $226.24M
Total Assets Q2 2025 · Dec 31, 2024 $283.98M
Eps Diluted Q2 2025 · Jun 30, 2025 −$0.28
Eps Diluted Q2 2025 · Jun 30, 2025 −$0.58
Eps Diluted Q2 2025 · Jun 30, 2024 −$0.45
Eps Diluted Q2 2025 · Jun 30, 2024 −$1.02
Eps Basic Q2 2025 · Jun 30, 2025 −$0.28
Eps Basic Q2 2025 · Jun 30, 2025 −$0.58
Eps Basic Q2 2025 · Jun 30, 2024 −$0.45
Eps Basic Q2 2025 · Jun 30, 2024 −$1.02
Sga Expense Q2 2025 · Jun 30, 2025 $6.86M
Sga Expense Q2 2025 · Jun 30, 2025 $14.1M
Sga Expense Q2 2025 · Jun 30, 2024 $7.33M
Sga Expense Q2 2025 · Jun 30, 2024 $15.04M
Rd Expense Q2 2025 · Jun 30, 2025 $21.79M
Rd Expense Q2 2025 · Jun 30, 2025 $43.42M
Rd Expense Q2 2025 · Jun 30, 2024 $23.8M
Rd Expense Q2 2025 · Jun 30, 2024 $49.33M
Net Income Q2 2025 · Jun 30, 2025 −$17.94M
Net Income Q2 2025 · Jun 30, 2025 −$36.77M
Net Income Q2 2025 · Mar 31, 2025 −$18.83M
Net Income Q2 2025 · Jun 30, 2024 −$22.98M
Net Income Q2 2025 · Jun 30, 2024 −$48M
Net Income Q2 2025 · Mar 31, 2024 −$25.02M
Operating Income Q2 2025 · Jun 30, 2025 −$21.1M
Operating Income Q2 2025 · Jun 30, 2025 −$44.01M
Operating Income Q2 2025 · Jun 30, 2024 −$26.63M
Operating Income Q2 2025 · Jun 30, 2024 −$54.83M
Revenue Q2 2025 · Jun 30, 2025 $7.56M
Revenue Q2 2025 · Jun 30, 2025 $13.51M
Revenue Q2 2025 · Jun 30, 2024 $6.89M
Revenue Q2 2025 · Jun 30, 2024 $11.94M